Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$588M |
| 2 |
UnitedHealth
UNH
|
+$429M |
| 3 |
Johnson & Johnson
JNJ
|
+$333M |
| 4 |
Amazon
AMZN
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXE
Expand Energy Corp
EXE
|
+$322M |
| 2 |
JPMorgan Chase
JPM
|
+$304M |
| 3 |
K
Kellanova
K
|
+$164M |
| 4 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$159M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$156M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Financials | 18.7% |
| 3 | Industrials | 12.07% |
| 4 | Healthcare | 10.44% |
| 5 | Consumer Discretionary | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Broadway Financial
BYFC
$93.8M
| $164K | ﹤0.01% |
22,920
+1,361
| +6% | +$10.3K |
|
3152
Star Bulk Carriers
SBLK
$3.21B
| $158K | ﹤0.01% |
10,173
| – | – |
|
|
KZR
3153
DELISTED
Kezar Life Sciences
KZR
| $158K | ﹤0.01% |
32,310
| – | – |
|
3154
Larimar Therapeutics
LRMR
$397M
| $156K | ﹤0.01% |
72,649
-8,501
| -10% | -$26.9K |
|
|
NOTV
3155
DELISTED
Inotiv
NOTV
| $155K | ﹤0.01% |
70,173
+38,547
| +122% | +$141K |
|
3156
Lightpath Technologies
LPTH
$651M
| $155K | ﹤0.01% |
77,050
+22,507
| +41% | +$61.9K |
|
3157
SR Bancorp
SRBK
$142M
| $155K | ﹤0.01% |
+12,945
| New | +$155K |
|
3158
Pitney Bowes
PBI
$2.37B
| $152K | ﹤0.01% |
16,833
-85,376
| -84% | -$773K |
|
|
TAIT
3159
DELISTED
Taitron Components
TAIT
| $151K | ﹤0.01% |
59,843
+4,318
| +8% | +$11.1K |
|
3160
Coffee Holding Co
JVA
$19.5M
| $149K | ﹤0.01% |
41,993
+9,730
| +30% | +$47.9K |
|
|
CMLS
3161
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $141K | ﹤0.01% |
319,574
-134,632
| -30% | -$97.4K |
|
3162
US Global Investors
GROW
$35.5M
| $140K | ﹤0.01% |
61,944
| – | – |
|
3163
Lee Enterprises
LEE
$172M
| $139K | ﹤0.01% |
13,402
-18,256
| -58% | -$205K |
|
|
CVAC
3164
DELISTED
CureVac
CVAC
| $138K | ﹤0.01% |
+49,607
| New | +$173K |
|
3165
PMV Pharmaceuticals
PMVP
$59.2M
| $137K | ﹤0.01% |
126,004
| – | – |
|
3166
Apyx Medical
APYX
$173M
| $136K | ﹤0.01% |
99,300
-8,982
| -8% | -$12.4K |
|
3167
Purple Innovation
PRPL
$35.3M
| $134K | ﹤0.01% |
7,081
| – | – |
|
3168
Sera Prognostics
SERA
$79.9M
| $134K | ﹤0.01% |
36,429
-3,276
| -8% | -$16.7K |
|
3169
Ironwood Pharmaceuticals
IRWD
$696M
| $133K | ﹤0.01% |
90,401
-128,021
| -59% | -$305K |
|
3170
Lantern Pharma
LTRN
$33.6M
| $133K | ﹤0.01% |
37,483
+934
| +3% | +$3.88K |
|
|
QVCGA
3171
DELISTED
QVC Group Inc Series A
QVCGA
| $133K | ﹤0.01% |
13,212
-211
| -2% | -$3.35K |
|
3172
Dyne Therapeutics
DYN
$4.7B
| $131K | ﹤0.01% |
12,569
-87,009
| -87% | -$1.24M |
|
|
FIRY
3173
Firy Inc
FIRY
$148M
| $130K | ﹤0.01% |
28,823
| – | – |
|
3174
CuriosityStream
CURI
$145M
| $129K | ﹤0.01% |
+48,063
| New | +$117K |
|
3175
Lightbridge
LTBR
$271M
| $127K | ﹤0.01% |
17,024
-2,014
| -11% | -$17.9K |
|
Similar funds
Dimensional Fund Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Dimensional Fund Advisors held 3,398 positions worth $402B, down 3.4% from $416B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 4%. Dimensional Fund Advisors opened 59 new positions and exited 78, leaving the 3,398-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2025 buy was Sandisk: 849,963 shares worth $40.5M.
- Dimensional Fund Advisors added most to Apple in Q1 2025, an estimated $588M increase.
- Dimensional Fund Advisors's biggest Q1 2025 reduction was Expand Energy Corp, cutting an estimated $322M.
- Dimensional Fund Advisors fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $159M.
- Dimensional Fund Advisors's ten largest holdings make up 15% of its $402B portfolio in Q1 2025.
- Dimensional Fund Advisors opened 59 new positions and closed 78 in Q1 2025.
- Dimensional Fund Advisors's portfolio value fell 3.4% quarter-over-quarter to $402B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2025, filed 13 May 2025.